Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease-Reference-Cited by-同舟云学术

Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease

Published:2014-04 Issue: Volume:64 Page:79-87
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Davies Sian E.,Hallett Penelope J.,Moens Thomas,Smith Gaynor,Mangano Emily,Kim Hyoung Tae,Goldberg Alfred L.,Liu Ji-Long,Isacson Ole,Tofaris George K.

Funder

Wellcome Trust/Acad.Med.Sci

Wellcome Trust Intermediate Clinical Fellowship

The Michael J. Fox Foundation

The Consolidated Anti-Aging Foundation

The Harold and Ronna Cooper Family

Miller Consortium for the Development of Nervous System Therapies

Publisher

Elsevier BV

Subject

Neurology

Reference33 articles.

1. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease;Auluck;Science,2002

2. Tyrosine and serine phosphorylation of α-synuclein have opposing effects on neurotoxicity and soluble oligomer formation;Chen;J. Clin. Invest.,2009

3. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy;Chung;J. Neurosci.,2009

4. Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression;Chung;Proc. Natl. Acad. Sci. U. S. A.,2009

5. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo;Cullen;Mol. Brain,2009

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Implications and Regulations of Protein Post-translational Modifications in Parkinsons Disease;Cellular and Molecular Neurobiology;2024-07-03

2. The effects of post-translational modifications on alpha-synuclein aggregation and immune cell activation in Parkinson’s disease;Exploration of Neuroprotective Therapy;2023-10-26

3. Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review;International Journal of Molecular Sciences;2023-07-03

4. Neuronal Vulnerability to Degeneration in Parkinson’s Disease and Therapeutic Approaches;CNS & Neurological Disorders - Drug Targets;2023-04-26

5. Roles of Ubiquitin Ligases and Deubiquitylases in Parkinson?s Disease;PROG BIOCHEM BIOPHYS;2023